FILE:CELG/CELG-8K-20110104090122.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
o
o
o
 
 
 
 
On December 30, 2010, Celgene Corporation announced that it will provide an overview of the company at the Goldman Sachs Healthcare CEOs Unscripted Conference at 3:15 p.m. ET on Thursday, January 6, 2011 and at the 29 Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011 at 11:00 a.m. ET.
th
Attached hereto and incorporated herein by reference as Exhibit 99.1 is the Press Release announcement.
Exhibit 99.1  Press Release dated December 30, 2010
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CELGENE CORPORATION
Date: January 4, 2011
By: Name: Jacqualyn A. Fouse Title: Sr. Vice President and Chief Financial Officer
/s/ Jacqualyn A. Fouse                                           

Exhibit 99.1
today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the companys Web site at www.celgene.com. Celgene management will provide an overview of the company.
SUMMIT, NJ  (December 30, 2010)  Celgene Corporation (NASDAQ: CELG)
On Thursday, January 6, 2011, Celgene will present at the Goldman Sachs Healthcare CEOs Unscripted Conference at 3:15 p.m. ET.
On Monday, January 10, 2011, Celgene will present at the 29th Annual J.P. Morgan Healthcare Conference at 11:00 a.m. ET.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the companys Web site at www.celgene.com.
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the companys control. The companys actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the companys filings with the Securities and Exchange Commission, such as the companys
Form 10-K
, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.


